PTC Therapeutics, Inc.
PTCTNasdaqCIK 1070081HealthcareFiscal year ends Dec 31
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:31 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001104659-26-120223 |
| 2026-10-2916:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120200 |
| 2026-09-2116:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001070081-26-000023 |
| 2026-08-2816:06 ET | 8-K | 1.01 Entry into a material agreement | 0001070081-26-000019 |
| 2026-08-1307:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-095424 |
| 2026-07-3016:32 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001070081-26-000017 |
| 2026-07-3016:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-26-000016 |
| 2026-06-1816:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-075731 |
| 2026-06-1607:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074292 |
| 2026-06-0917:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-071916 |
| 2026-06-0517:15 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-071040 |
| 2026-05-0716:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001070081-26-000012 |
| 2026-05-0716:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-26-000011 |
| 2026-04-2816:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-26-000006 |
| 2026-04-2016:30 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001104659-26-045528 |
| 2026-03-2509:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-034207 |
| 2026-02-1916:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-017575 |
| 2026-02-1916:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-017546 |
| 2026-02-1217:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-014414 |
| 2026-01-1212:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002799 |
| 2025-12-2916:05 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-25-124837 |
| 2025-11-0416:33 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001070081-25-000028 |
| 2025-11-0416:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000026 |
| 2025-08-1908:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011658 |
| 2025-08-0716:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010796 |
| 2025-08-0716:30 ET | 8-K | 1.01 Entry into a material agreement | 0001558370-25-010786 |
| 2025-08-0716:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-010770 |
| 2025-07-2817:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-009663 |
| 2025-06-1717:00 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-008694 |
| 2025-05-0616:34 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001070081-25-000019 |
| 2025-05-0616:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000018 |
| 2025-05-0507:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000014 |
| 2025-04-3016:30 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001558370-25-006007 |
| 2025-03-2811:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-029124 |
| 2025-02-2716:32 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001070081-25-000012 |
| 2025-02-2716:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000011 |
| 2025-01-1314:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-25-000007 |
| 2025-01-0316:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001070081-25-000004 |
| 2024-12-0207:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000029 |
| 2024-11-2707:08 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000026 |
| 2024-11-0716:35 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001070081-24-000023 |
| 2024-11-0716:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000021 |
| 2024-10-1806:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013387 |
| 2024-08-2716:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-093470 |
| 2024-08-0816:35 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001070081-24-000017 |
| 2024-08-0816:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000015 |
| 2024-06-2807:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001070081-24-000010 |
| 2024-06-2007:55 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-009313 |
| 2024-05-2007:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008446 |
| 2024-04-2616:30 ET | DEF 14A | Proxy statementPeriod 2024-06-18 | 0001558370-24-005924 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:45 ET. Listed shows no prices and gives no investment advice.